Nifurtimox: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nifurtimox. Educational only — not medical advice.
Labeled uses
LAMPIT is indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi [see Clinical Studies (14 )].
Source: FDA labeling via NIH DailyMed (set 90d09714…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.